Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80
Document › Details

Bruker Corporation. (9/7/18). "Press Release: Bruker Corporation to Present at the 16th Annual Morgan Stanley Global Healthcare Conference". Billerica, MA.

Region Region New York, NY
  Country United States (USA)
Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Organisation 2 Morgan Stanley & Co. LLC
  Group Morgan Stanley (Group)
Products Product Morgan Stanley Global Healthcare Conference 2018 New York
  Product 2 analytical instrument
Index term Index term Bruker–Morgan Stanley: investor conference, 201809 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Busse, Falko (Bruker Corp 201805– President of Bruker BioSpin Group joined 2015 before Philips Healthcare)
     


Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 16th Annual Morgan Stanley Global Healthcare Conference. Frank Laukien, President and Chief Executive Officer and Falko Busse, President of the Bruker BioSpin Group, will participate in a "fireside chat" Q&A session on behalf of the company on Thursday, September 13th, 2018 at 12:55 PM Eastern Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.


About Bruker Corporation (NASDAQ: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

   
Record changed: 2018-09-09

Advertisement

Picture [iito] No Tracking 650x80px

More documents for Bruker (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top